Kala Bio (LTS:0JQ2) FCF Yield % : -161.42 (As of May. 25, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Kala Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Kala Bio's Trailing 12-Month Free Cash Flow is $-29.60 Mil, and Market Cap is $18.34 Mil. Therefore, Kala Bio's FCF Yield % for today is -161.42%.

The historical rank and industry rank for Kala Bio's FCF Yield % or its related term are showing as below:

LTS:0JQ2' s FCF Yield % Range Over the Past 10 Years
Min: -1673.26 Med: -79.18 Max: -13.18
Current: -161.42

During the past 9 years, the highest FCF Yield % of Kala Bio was -13.18%. The lowest was -1673.26%. And the median was -79.18%.

LTS:0JQ2's FCF Yield % is ranked worse than
90.28% of 1553 companies
in the Biotechnology industry
Industry Median: -14.53 vs LTS:0JQ2: -161.42

Kala Bio's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Kala Bio FCF Yield % Historical Data

The historical data trend for Kala Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kala Bio FCF Yield % Chart

Kala Bio Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-51.97

-22.85

-144.51

-401.82

-148.08

Kala Bio Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-115.55	-85.44	-54.34	-159.89	-193.21

Competitive Comparison of Kala Bio's FCF Yield %

For the Biotechnology subindustry, Kala Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kala Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kala Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Kala Bio's FCF Yield % falls into.

Kala Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Kala Bio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-28.537	/	19.270888206
	=	-148.08%

Kala Bio's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-10.857	*	4	/	22.4772143505
	=	-193.21%

Kala Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Kala Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Kala Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kala Bio (LTS:0JQ2) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kala Bio Inc (LTS:0JQ2) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

KALA:USA 27F0:Germany

Address

1167 Massachusetts Avenue, Arlington, MA, USA, 02476

Website

https://www.kalarx.com

Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare and severe eye diseases. KALA's lead product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.

Kala Bio (LTS:0JQ2) Headlines

No Headlines